Basic Information
RNALocate ID: | RLID:11002003 |
RNA Symbol: | hsa-miR-320a-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-320a |
RNA ID: | miRBase:MIMAT0000510 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 20976003 |
Tissue/Cell Line: | Breast cancer cell line (MCF-7) |
Method: | Microarray |
Description: | Because of the suggested roles of extracellular miRNAs in signaling and diagnosis, we investigated whether the intracellular and extracellular miRNA composition are the same. To answer this question, we performed microRNA microarray analyses of MCF7 cellular (c) and extracellular (x) RNAs (Figure 2A), and found that about 66% of the released miRNAs are at an abundance that closely reflects the cellular miRNA abundance (Figures 2B and 2C). This finding is in agreement with a model wherein most, but not all miRNAs are released passively by mass action. Data are collected from Figure 2. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001858 | Cytoplasm | Cardiomyocytes | 31837603 |
RLID:01001859 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001860 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001861 | Mitochondrion | HEK-293 cells|HeLa cells | 27396686 |
RLID:01001862 | Mitochondrion | HEK-293 cells|HeLa cells | 27563705 |
RLID:01001863 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001864 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001865 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001866 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001867 | Nucleus | Cardiomyocytes | 31837603 |
RLID:01001868 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001869 | Nucleus | Neural progenitor cells | 21363885 |
RLID:11001998 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
RLID:11001999 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
RLID:11002000 | Exosome | Pooled sera | 27278097 |
RLID:11002001 | Exosome | Serum | 18589210 |
RLID:11002002 | Exosome | Glioblastoma cells | 19011622 |
RLID:11002004 | Exosome | Ovarian follicular fluid | 22116803 |
RLID:11002005 | Exosome | Brain tissue | 23382797 |
RLID:11002006 | Exosome | Plasma | 23663360 |
RLID:11002007 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11002008 | Exosome | Serum | 25135963 |
RLID:11002009 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
RLID:11002010 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
RLID:11002011 | Exosome | Cerebrospinal fluid | 25420022 |
RLID:11002012 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11002013 | Microvesicle | Glioblastoma cells | 19011622 |
RLID:11002014 | Microvesicle | Plasma | 23077538 |
RLID:11002015 | Microvesicle | Seminal plasma | 23539611 |
RLID:11002016 | Microvesicle | Follicular fluid | 23666971 |
RLID:11002017 | Microvesicle | Serum | 24797360 |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-320a-3p | Cardiomyopathy | MNDR-E-MI-39294 |
MNDR | hsa-miR-320a-3p | Diffuse large b cell lymphoma | MNDR-E-MI-39295 |
MNDR | hsa-miR-320a-3p | Splenic marginal zone lymphoma | MNDR-E-MI-39296 |
MNDR | hsa-miR-320a-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-39297 |
MNDR | hsa-miR-320a-3p | Follicular lymphoma | MNDR-E-MI-39298 |
MNDR | hsa-miR-320a-3p | Medulloblastoma | MNDR-E-MI-39299 |
MNDR | hsa-miR-320a-3p | Lymphoma | MNDR-E-MI-39300 |
MNDR | hsa-miR-320a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-39301 |
MNDR | hsa-miR-320a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-39302 |
MNDR | hsa-miR-320a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-39303 |
MNDR | hsa-miR-320a-3p | Breast cancer luminal | MNDR-E-MI-39304 |
MNDR | hsa-miR-320a-3p | Lupus nephritis | MNDR-E-MI-39305 |
MNDR | hsa-miR-320a-3p | Prostate cancer | MNDR-E-MI-39306 |
MNDR | hsa-miR-320a-3p | Alzheimer disease | MNDR-E-MI-39307 |
MNDR | hsa-miR-320a-3p | Sickle cell anemia | MNDR-E-MI-39308 |
MNDR | hsa-miR-320a-3p | Ataxia telangiectasia | MNDR-E-MI-39309 |
MNDR | hsa-miR-320a-3p | Lung cancer | MNDR-E-MI-39310 |
MNDR | hsa-miR-320a-3p | Parkinson disease | MNDR-E-MI-39311 |
MNDR | hsa-miR-320a-3p | Breast cancer | MNDR-E-MI-39312 |
MNDR | hsa-miR-320a-3p | Pituitary neoplasms | MNDR-E-MI-39313 |
MNDR | hsa-miR-320a-3p | Pancreatic cancer | MNDR-E-MI-39314 |
MNDR | hsa-miR-320a-3p | Melanoma | MNDR-E-MI-39315 |
MNDR | hsa-miR-320a-3p | Wilms tumor | MNDR-E-MI-39316 |
MNDR | hsa-miR-320a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-39317 |
MNDR | hsa-miR-320a-3p | Ovarian neoplasms | MNDR-E-MI-39318 |
MNDR | hsa-miR-320a-3p | Kidney cancer | MNDR-E-MI-39319 |
MNDR | hsa-miR-320a-3p | Glioblastoma | MNDR-E-MI-39320 |
MNDR | hsa-miR-320a-3p | Astrocytoma | MNDR-E-MI-39321 |
MNDR | hsa-miR-320a-3p | Glioma | MNDR-E-MI-39322 |
MNDR | hsa-miR-320a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-39323 |
MNDR | hsa-miR-320a-3p | Osteosarcoma | MNDR-E-MI-39324 |
MNDR | hsa-miR-320a-3p | Inclusion body myositis | MNDR-E-MI-39325 |
MNDR | hsa-miR-320a-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-39326 |
MNDR | hsa-miR-320a-3p | Uterus cancer | MNDR-E-MI-39327 |
MNDR | hsa-miR-320a-3p | Pituitary adenoma | MNDR-E-MI-39328 |
MNDR | hsa-miR-320a-3p | Lung squamous cell carcinoma | MNDR-E-MI-39329 |
MNDR | hsa-miR-320a-3p | Non-small cell lung cancer | MNDR-E-MI-39330 |
MNDR | hsa-miR-320a-3p | Clear cell renal cell carcinoma | MNDR-E-MI-39331 |
MNDR | hsa-miR-320a-3p | Cholangiocarcinoma | MNDR-E-MI-39332 |
MNDR | hsa-miR-320a-3p | Esophageal cancer | MNDR-E-MI-39333 |
MNDR | hsa-miR-320a-3p | Encephalopathy bovine spongiform | MNDR-E-MI-39334 |
MNDR | hsa-miR-320a-3p | Heart failure | MNDR-E-MI-39335 |
MNDR | hsa-miR-320a-3p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-39336 |
MNDR | hsa-miR-320a-3p | Encephalomyelitis | MNDR-E-MI-39337 |
MNDR | hsa-miR-320a-3p | Leukoencephalopathy progressive multifocal | MNDR-E-MI-39338 |
MNDR | hsa-miR-320a-3p | Hepatocellular carcinoma | MNDR-E-MI-39339 |
MNDR | hsa-miR-320a-3p | B-cell lymphoma | MNDR-E-MI-39340 |
MNDR | hsa-miR-320a-3p | Malignant pleural mesothelioma | MNDR-E-MI-39341 |
MNDR | hsa-miR-320a-3p | Retinoblastoma | MNDR-E-MI-39342 |
MNDR | hsa-miR-320a-3p | Neuroblastoma | MNDR-E-MI-39343 |
MNDR | hsa-miR-320a-3p | Burkitt lymphoma | MNDR-E-MI-39344 |
MNDR | hsa-miR-320a-3p | Acute myeloid leukemia | MNDR-E-MI-39345 |
MNDR | hsa-miR-320a-3p | Colorectal cancer | MNDR-E-MI-39346 |
MNDR | hsa-miR-320a-3p | Multiple myeloma | MNDR-E-MI-39347 |
MNDR | hsa-miR-320a-3p | Acute lymphocytic leukemia | MNDR-E-MI-39348 |
MNDR | hsa-miR-320a-3p | Nasopharyngeal cancer | MNDR-E-MI-39349 |
MNDR | hsa-miR-320a-3p | Nerve degeneration | MNDR-E-MI-39350 |
MNDR | hsa-miR-320a-3p | Prostatic neoplasms | MNDR-E-MI-39351 |
MNDR | hsa-miR-320a-3p | Reperfusion injury | MNDR-E-MI-39352 |
MNDR | hsa-miR-320a-3p | Chronic pain | MNDR-E-MI-39353 |
MNDR | hsa-miR-320a-3p | Barrett's carcinogenesis | MNDR-E-MI-39354 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCG2 | Homo sapiens | RR00024747 |
TOP